Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Leukemia 20Lymphoma 19Breast Neoplasms 19Burkitt Lymphoma 15Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 8Central Nervous System Neoplasms 8Lymphoma, Non-Hodgkin 7Anemia, Refractory, with Excess of Blasts 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5Dendritic Cell Sarcoma, Interdigitating 5Acquired Immunodeficiency Syndrome 5Osteosarcoma 4Myeloproliferative Disorders 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4HIV Infections 4Congenital Abnormalities 4

Interventions

Carboplatin 43Paclitaxel 33Specimen Handling 15Taxes 14Cyclophosphamide 14Magnetic Resonance Spectroscopy 12Gemcitabine 12Biopsy 12Bevacizumab 12aldesleukin 11Immunoglobulin G 11Disulfides 11veliparib 9Topotecan 9Doxorubicin 9Cisplatin 9Docetaxel 8fludarabine 7olaparib 6liposomal doxorubicin 6Oxaliplatin 6Chemotherapy, Adjuvant 5talazoparib 4sargramostim 4pembrolizumab 4cediranib 4Nivolumab 4Fluorouracil 4Drug Therapy 4sapanisertib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Ovarian Neoplasms × Methotrexate × Clear all
NCT00002487 2013-09-17

Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡